| Literature DB >> 23926383 |
Toru Kikuchi1, Makoto Uchiyama.
Abstract
The origins of adult disease are considered to relate to fetal undernutrition, and this concept is termed "developmental origins of adult health and disease" (DOHaD). Here, we describe several epidemiological studies performed in Japan and discuss whether DOHaD is applicable to children in present day Japan. In a study of healthy children and young adults, it was found that systolic blood pressure, total cholesterol and adiponectin were associated with birth weight. Hyperinsulinemia, high blood pressure, elevated transaminase levels and prevalence of metabolic syndrome in obese children were inversely correlated with birth weight and positively correlated with current weight and waist circumference. Birth weight was related to the development of type 2 diabetes in children. DOHaD is therefore considered to be applicable in Japan. The key considerations of DOHaD are the following two mismatches. The first mismatch pertains to growth and development in response to environmental influences, especially those of nutrition. The second mismatch pertains to the prenatal versus postnatal environment. We consider that the chance of children in present day Japan developing adult diseases is determined by the above mismatches. Pediatricians and schoolteachers should therefore understand the concept of DOHaD, so that they can educate both children and their families regarding an appropriate diet to reduce the likelihood of developing adult diseases in later life.Entities:
Keywords: adiponectin; birth weight; blood pressure; insulin; obesity
Year: 2010 PMID: 23926383 PMCID: PMC3687626 DOI: 10.1297/cpe.19.83
Source DB: PubMed Journal: Clin Pediatr Endocrinol ISSN: 0918-5739
Epidemiological studies of the relation of birth weight and risks factors to cardiovascular disease in Japan
Multiple regression analyses of adiponectin, insulin and GPT with birth weight and waist circumference adjusted for sex and age among 600 obese boys and 283 obese girls from Japan
| Independent variables | Dependent variables | Adiponectin | Insulin | GPT | |||
| β | p | β | p | β | p | ||
| Model 1 | Waist circumference | –0.235 | <0.0001 | 0.591 | <0.0001 | 0.453 | <0.0001 |
| Birth weight | 0.09 | <0.01 | –0.139 | <0.0001 | –0.131 | <0.0001 | |
| Model 2 | Waist circumference | –0.236 | <0.0001 | 0.595 | <0.0001 | 0.457 | <0.0001 |
| Birth weight SD score | 0.087 | <0.01 | –0.150 | <0.0001 | –0.14 | <0.0001 | |
GPT, glutamic pyruvic transaminase.
Prevalence of metabolic syndrome and the mean levels of fasting serum insulin in 261 Japanese obese boys according to birth weight and waist circumference after being divided into 3 groups
| Waist circumference (cm) | Birth weight (g) | |||
| 1,740–3,120 | 3,130–3,425 | 3,430–4,875 | Total | |
| 64.0–82.0 | 4 (10.8%) | 0 (0.0%) | 1 (3.8%) | 5 (5.6%) |
|
|
|
|
| |
| 37 | 27 | 26 | 90 | |
| 82.5–88.5 | 7 (29.2%) | 3 (10.3%) | 6 (18.2%) | 16 (18.6%) |
|
|
|
|
| |
| 24 | 29 | 33 | 86 | |
| 89.0–116.0 | 9 (33.3%) | 8 (26.7%) | 5 (17.9%) | 22 (25.9%) |
|
|
|
|
| |
| 27 | 30 | 28 | 85 | |
| Total | 20 (22.7%) | 11 (12.8%) | 12 (13.8%) | 43 (16.5%) |
|
|
|
|
| |
| 88 | 86 | 87 | 261 | |
Upper stand: number with metabolic syndrome (%). Middle stand: the mean level of fasting serum insulin (µU/ml). Lower stand: total number in each group.
Prevalence of metabolic syndrome and the mean levels of fasting serum insulin in 125 Japanese obese girls according to birth weight and waist circumference after being divided into 3 groups
| Waist circumference (cm) | Birth weight (g) | |||
| 1,845–3,040 | 3,044–3,375 | 3,390–4,000 | Total | |
| 69.0–80.5 | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
|
|
|
|
| |
| 12 | 19 | 11 | 42 | |
| 86.0–85.5 | 3 (20.0%) | 1 (11.1%) | 0 (0.0%) | 4 (10.0%) |
|
|
|
|
| |
| 15 | 9 | 16 | 40 | |
| 86.0–114.5 | 11 (73.3%) | 1 (7.7%) | 2 (13.3%) | 14 (32.6%) |
|
|
|
|
| |
| 15 | 13 | 15 | 43 | |
| Total | 14 (33.3%) | 2 (4.9%) | 2 (4.8%) | 18 (14.4%) |
|
|
|
|
| |
| 42 | 41 | 42 | 125 | |
Upper stand: number with metabolic syndrome (%). Middle stand: the mean level of fasting serum insulin (µU/ml). Lower stand: total number in each group.